6JG-18022-04449

3 vaccinations 15 coded responses 37 check-ins 15 free-text entries 0 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 015 / MA
Registered: 2021-02-03

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-03
Registered in v-safe
2021-02-03
Dose 1 — Pfizer-BioNTech
2021-02-03
Health check-in — day 0, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-04
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-02-05
Survey response — days 1–6 daily, dose 1
MedDRA: Breast feeding, Diarrhoea, Irritability — Feeling: Good · Fatigue or tiredness

Free text: Breastfeeding - 17m/o with diarrhea & increased irritability x2days, but may be cutting canines

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-10
Survey response — day 7, dose 1
MedDRA: Dermatitis — Feeling: Good · Headache

Free text: Scalp dermatitis worsening since vaccine but confounding variables, likely unrelated to vaccine itself

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-24
Dose 2 — Pfizer-BioNTech
2021-02-24
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-02-25
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Mental fog

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-02-27
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Swollen axillary lymph node

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness

Free text: Axillary lymph node swelling

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-01
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Unilateral axillary lymph node swelling

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-02
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Unilateral axillary lymph node swelling

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-17
Survey response — day 21, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Posterior cervical lymph node swelling (opposite side of injection) - noting bc of unilateral axillary lymph node swelling s/p injection, though likely unrelated

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-31
Survey response — day 35, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Ongoing mild lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-26
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-25
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-09
Dose 3 — Pfizer-BioNTech
2021-12-11
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Unilateral lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-12
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Unilateral axillary lymphadenopathy - improving

MedDRA releases: 2024-11 · check-in free text available
2021-12-13
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Nausea

Free text: lymphadenopathy, improving

MedDRA releases: 2024-11 · check-in free text available
2021-12-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-12-16
Survey response — day 7, dose 3
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Very very mild lymphadenopathy, continuing to improve

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-30
Survey response — day 21, dose 3
MedDRA: Rhinorrhoea, Upper-airway cough syndrome — Feeling: Fair

Free text: Rhinorrhea, postnasal drip

MedDRA releases: 2024-11 · check-in free text available
2022-01-06
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-14
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-20
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-10
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-10
Survey response — 12 months, dose 3
MedDRA: COVID-19, Lymphadenopathy, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: 1st (and only known to date) COVID infection on 8/5/2022. Return of unilateral axillary lymphadenopathy after most recent booster 3 wks ago which has since resolved.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-03	Pfizer-BioNTech
2	2021-02-24	Pfizer-BioNTech
3	2021-12-09	Pfizer-BioNTech	No

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-05

Systemic reaction (other): Breastfeeding - 17m/o with diarrhea & increased irritability x2days, but may be cutting canines

Release 4 — day 7, dose 1

2021-02-10

Systemic reaction (other): Scalp dermatitis worsening since vaccine but confounding variables, likely unrelated to vaccine itself

Release 4 — days 1–6 daily, dose 2

2021-02-25

Systemic reaction (other): Mental fog

2021-02-27

Systemic reaction (other): Swollen axillary lymph node

2021-02-28

Systemic reaction (other): Axillary lymph node swelling

2021-03-01

Systemic reaction (other): Unilateral axillary lymph node swelling

2021-03-02

Systemic reaction (other): Unilateral axillary lymph node swelling

Release 5 — day 21, dose 2

2021-03-17

Symptoms: Posterior cervical lymph node swelling (opposite side of injection) - noting bc of unilateral axillary lymph node swelling s/p injection, though likely unrelated

Release 6 — day 35, dose 2

2021-03-31

Symptoms: Ongoing mild lymphadenopathy

Release 10 — days 1–6 daily, dose 3

2021-12-11

Systemic reaction (other): Unilateral lymphadenopathy

2021-12-12

Systemic reaction (other): Unilateral axillary lymphadenopathy - improving

2021-12-13

Systemic reaction (other): lymphadenopathy, improving

Release 10 — day 7, dose 3

2021-12-16

Systemic reaction (other): Very very mild lymphadenopathy, continuing to improve

Release 10 — day 21, dose 3

2021-12-30

Symptoms: Rhinorrhea, postnasal drip

Release 12 — 12 months, dose 3

2022-12-10

Symptoms: 1st (and only known to date) COVID infection on 8/5/2022. Return of unilateral axillary lymphadenopathy after most recent booster 3 wks ago which has since resolved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Pre-existing disease	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Upper-airway cough syndrome	·	·	✓
SRO	Breast feeding	✓	✓	✓
SRO	Dermatitis	✓	✓	✓
SRO	Diarrhoea	✓	✓	✓
SRO	Feeling abnormal	✓	✓	✓
SRO	Irritability	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release